A molecular mechanism for the anti-inflammatory effect of taurine-conjugated 5-aminosalicylic acid in inflamed colon

Molecular Pharmacology

Volumn 69, Issue 4, 2006, Pages 1405-1412

  Kim, Heejung ^a   Jeon, Hyunchu ^a   Kong, Hyesik ^b   Yang, Youngwook ^a   Choi, Boim ^a   Young, Mi Kim ^a   Neckers, Len ^b   Jung, Yunjin ^a  

^a Pusan National University   (South Korea)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINOSALICYLTAURINE; CHLORAMINE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESALAZINE; PRODRUG; TAURINE; TAURINE CHLORAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; DRUG EFFECT; DRUG MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; RAT; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLITIS; COLON; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MESALAMINE; NF-KAPPA B; PHOSPHORYLATION; RATS; SERINE; TAURINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645101399     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.020578     Document Type: Article

References (40)

1. Andrews NC and Faller DV (1991) A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499.
2. Auphan N, DiDonato JA, Rosette C, Helmberg A, and Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science (Wash DC) 270:286-290.
3. Baeuerle PA and Baltimore D (1988) I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science (Wash DC) 242:540-546.
4. Barua M, Liu Y, and Quinn MR (2001) Taurine chloramine inhibits inducible nitric oxide synthase and TNF-alpha gene expression in activated alveolar macrophages: decreased NF-kappaB activation and IkappaB kinase activity. J Immunol 167:2275-2281.
5. Biddle WL and Miner PB Jr (1990) Long-term use of mesalamine enemas to induce remission in ulcerative colitis. Gastroenterology 99:113-118.
6. Cargnoni A, Ceconi C, Gaia G, Agnoletti L, and Ferrari R (2002) Cellular thiols redox status: a switch for NF-kappaB activation during myocardial post-ischaemic reperfusion. J Mol Cell Cardiol 34:997-1005.
7. Chilov D, Camenisch G, Kvietikova I, Ziegler U, Gassmann M, and Wenger RH (1999) Induction and nuclear translocation of hypoxia-inducible factor-1 (HIF-1): heterodimerization with ARNT is not necessary for nuclear accumulation of HIF-1alpha. J Cell Sci 112:1203-1212.
8. Conner EM, Brand S, Davis JM, Laroux FS, Palombella VJ, Fuseler JW, Kang DY, Wolf RE, and Grisham MB (1997) Proteasome inhibition attenuates nitric oxide synthase expression, VCAM-1 transcription and the development of chronic colitis. J Pharmacol Exp Ther 282:1615-1622.
9. Crotty B and Jewell DP (1992) Drug therapy of ulcerative colitis. Br J Clin Pharmacol 34:189-198.
10. Egan LJ, Mays DC, Huntoon CJ, Bell MP, Pike MG, Sandborn WJ, Lipsky JJ, and McKean DJ (1999) Inhibition of interleukin-1-stimulated NF-κB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity. J Biol Chem 274:26448-26453.
11. Fiocchi C (1997) Intestinal inflammation: a complex interplay of immune and non-immune cell interactions. Am J Physiol 273:G769-G775.
12. Garcia-Pineres AJ, Castro V, Mora G, Schmidt TJ, Strunck E, Pahl HL, and Merfort I (2001) Cysteine 38 in p65/NF-κB plays a crucial role in DNA binding inhibition by sesquiterpene lactones. J Biol Chem 276:39713-39720.
13. Hibi T, Inoue N, Ogata H, and Naganuma M (2003) Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease. J Gastroenterol 38 (Suppl 15):36-42.
14. Hu Y, Baud V, Delhase M, Zhang P, Deerinck T, Ellisman M, Johnson R, and Karin M (1999) Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science (Wash DC) 284:316-320.
15. Jobin C, Morteau O, Han DS, and Balfour Sartor R (1998) Specific NF-kappaB blockade selectively inhibits tumour necrosis factor-alpha-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells. Immunology 95:537-543.
16. Jung YJ, Kim HH, Kong HS, and Kim YM (2003) Synthesis and properties of 5-aminosalicyl-taurine as a colon-specific prodrug of 5-aminosalicylic acid. Arch Pharm Res 26:264-269.
17. Kaiser GC, Yan F, and Polk DB (1999) Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kappaB activation in mouse colonocytes. Gastroenterology 116:602-609.
18. Kanayama A, Inoue J, Sugita-Konishi Y, Shimizu M, and Miyamoto Y (2002) Oxidation of IκBα at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-κB activation. J Biol Chem 277:24049-24056.
19. Kunsch C, Ruben SM, and Rosen CA (1992) Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation. Mol Cell Biol 12:4412-4421.
20. Li Q and Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2:725-734.
21. Marcinkiewicz J, Grabowska A, Bereta J, Bryniarski K, and Nowak B (1998) Taurine chloramine down-regulates the generation of murine neutrophil inflammatory mediators. Immunopharmacology 40:27-38.
22. Marquez LA and Dunford HB (1994) Chlorination of taurine by myeloperoxidase. Kinetic evidence for an enzyme-bound intermediate. J Biol Chem 269:7950-7956.
23. Mercurio F and Manning AM (1999) Multiple signals converging on NF-kappaB. Curr Opin Cell Biol 11:226-232.
24. Neurath MF, Becker C, and Barbulescu K (1998) Role of NF-kappaB in immune and inflammatory responses in the gut. Gut 43:856-860.
25. Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, and Strober W (1996) Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med 2:998-1004.
26. Nishi T, Shimizu N, Hiramoto M, Sato I, Yamaguchi Y, Hasegawa M, Aizawa S, Tanaka H, Kataoka K, Watanabe H, et al. (2002) Spatial redox regulation of a critical cysteine residue of NF-κB in vivo. J Biol Chem 277:44548-44556.
27. Novis BH, Korzets Z, Chen P, and Bernheim J (1988) Nephrotic syndrome after treatment with 5-aminosalicylic acid. Br Med J Clin Res 296:1442.
28. Peskin AV and Winterbourn CC (2001) Kinetics of the reactions of hypochlorous acid and amino acid chloramines with thiols, methionine and ascorbate. Free Radic Biol Med 30:572-579.
29. Sakurai H, Chiba H, Miyoshi H, Sugita T, and Toriumi W (1999) IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 274:30353-30356.
30. Schuller-Levis G, Quinn MR, Wright C, and Park E (1994) Taurine protects against oxidant-induced lung injury: possible mechanism(s) of action. Adv Exp Med Biol 359:31-39.
31. Sizemore N, Lerner N, Dombrowski N, Sakurai H, and Stark GR (2002) Distinct roles of the IκB kinase α and β subunits in liberating nuclear factor kappa B (NF-κB) from IκB and in phosphorylating the p65 subunit of NF-κB. J Biol Chem 277:3863-3869.
32. Son MW, Ko JI, Doh HM, Kim WB, Park TS, Shim MJ, and Kim BK (1998) Protective effect of taurine on TNBS-induced inflammatory bowel disease in rats. Arch Pharm Res 21:531-536.
33. Stapleton PP, Redmond HP, and Bouchier-Hayes DJ (1998) Myeloperoxidase (MPO) may mediate neutrophil adherence to the endothelium through upregulation of CD11B expression-an effect downregulated by taurine. Adv Exp Med Biol 442:183-192.
34. Tanaka K, Kawakami T, Tateishi K, Yashiroda H, and Chiba T (2001) Control of IkappaBalpha proteolysis by the ubiquitin-proteasome pathway. Biochimie 83:351-356.
35. Urban MB, Schreck R, and Baeuerle PA (1991) NF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunit. EMBO (Eur Mol Biol Organ) J 10:1817-1825.
36. Vermeulen L, De Wilde G, Notebaert S, Vanden Berghe W, and Haegeman G (2002) Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit. Biochem Pharmacol 64:963-970.
37. Yamamoto Y and Gaynor RB (2001) Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Investig 107:135-142.
38. Yan F and Polk DB (1999) Aminosalicylic acid inhibits IκB kinase α phosphorylation of IκBα in mouse intestinal epithelial cells. J Biol Chem 274:36631-36636.
39. Yang L, Chu JS, and Fix JA (2002) Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int J Pharm 235:1-15.
40. Yano H, Hirayama F, Kamada M, Arima H, and Uekama K (2002) Colon-specific delivery of prednisolone-appended alpha-cyclodextrin conjugate: alleviation of systemic side effect after oral administration. J Control Release 79:103-112.